Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,973
Closed -$239K 1705
2025
Q4
$239K Buy
+6,973
New +$207K ﹤0.01% 940
2025
Q3
Sell
-25,133
Closed -$706K 1162
2025
Q2
$706K Buy
25,133
+10,701
+74% +$338K 0.01% 790
2025
Q1
$521K Buy
+14,432
New +$581K 0.02% 788
2024
Q4
Sell
-31,033
Closed -$1M 1728
2024
Q3
$1M Buy
31,033
+5,719
+23% +$226K 0.02% 841
2024
Q2
$983K Buy
+25,314
New +$1.01M 0.02% 788
2023
Q3
Sell
-5,444
Closed -$238K 1738
2023
Q2
$238K Buy
+5,444
New +$185K 0.01% 1245

Other funds holding BRZE

Centiva Capital's BRZE Position: Q1 2026 in Review

Centiva Capital sold out of Braze (BRZE) in Q1 2026, closing a stake of 6,973 shares — an estimated $239K sold.

Centiva Capital first reported a position in BRZE in Q2 2023 and held it in 6 quarters. The position peaked at $1M in Q3 2024. 257 funds tracked by Wall St. Rank hold BRZE as of Q1 2026.

  • Centiva Capital reported no remaining Braze position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 6,973 Braze shares in Q1 2026, an estimated $239K.
  • Centiva Capital first reported a position in Braze in Q2 2023 and held it in 6 quarters.
  • Centiva Capital's Braze position peaked at $1M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Braze as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.